Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 07/03/17 | Current report filing |
|
3 | ||
| 06/20/17 | Current report filing |
|
3 | ||
| 06/13/17 | Current report filing |
|
4 | ||
| 06/07/17 | Current report filing |
|
28 | ||
| 05/19/17 | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. |
|
5 | ||
| 05/15/17 | Quarterly report pursuant to Section 13 or 15(d) |
|
 |
51 | |
| 05/15/17 | Current report filing |
|
8 | ||
| 05/12/17 | Current report filing |
|
6 | ||
| 05/12/17 | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
6 | ||
| 05/11/17 | Statement of changes in beneficial ownership of securities |
|
1 |